摘要
Abstract
Objective To study clinical effect of Smecta in treatment of colitis, diarrhea and the drug effect mechanism analysis, provide a reliable basis for the clinical. Methods In our hospital 162 cases of ulcerative colitis patients with diarrhea, which according to the drawing method is divided into the observation group and the control group. The control group were treated with oral sulfasalazine treatment, patients in acute period of 1g/time, four times a day, to be in remission after 0.5g/times, seriously ill patients sulfasalazine suppositories can be inserted into the anus, once a day;patients in the observation group was treated with Smecta treatment, three times a day, a bag three, seriously ill patients given a two bag, pour in 100mL water retention enema, once a day. And the incidence of adverse reactions compared the clinical efficacy of two groups of patients. Results The group of significant efficiency, efficiency, less efficient, total effective rate was 41.97%, 49.38%, 8.65%, the control group markedly effective, effective, less efficient, total effective rate was 37.04%, 43.21%, 19.75%, 80.25%, compared two groups of patients with significant differences (P < 0.05). The observation group and the control group took the adverse reaction rate were 4.94% and 11.11%, it showed significant difference (P <0.05). Conclusion Smecta treatment has a significant clinical effect of diarrhea and ulcerative colitis, and low incidence rate of adverse reaction, with a higher patient satisfaction, suitable for wide popularization and clinical application.关键词
思密达/临床疗效/治疗机制Key words
Smida/Clinical curative effect/Therapeutic mechanism分类
医药卫生
